Finance

Lists
Why is CRDL down 5,06%?
Dive Deeper
CRDL:TSE
Cardiol Therapeutics Inc
CAD 1,69
-5,06%
(-0,090) 1D
13 Okt., 14:58:54 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDL...
Open
CAD 1,75
High
CAD 1,76
Low
CAD 1,69
Mkt. cap
200,99 m
Avg. vol.
293,18 k
Volume
158,57 k
52-wk high
CAD 3,23
52-wk low
CAD 1,22
EPS
-CAD 0,34
Beta
0,66
Shares outstanding
116,82 m
No. of employees
18
Open
CAD 1,75
High
CAD 1,76
Low
CAD 1,69
Mkt. cap
200,99 m
Avg. vol.
293,18 k
Volume
158,57 k
52-wk high
CAD 3,23
52-wk low
CAD 1,22
EPS
-CAD 0,34
Beta
0,66
Shares outstanding
116,82 m
No. of employees
18
News stories
From web sources and news partners
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersOakville, Ontario, Kanada
SectorPharmaceutical industry
Websitecardiolrx.com
Last report
12 Aug. 2026
Fiscal period
Q2 2026
-CAD 0,05 / -CAD 0,10
+48,28%beat
Revenue / Est. (CAD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,79 m
2,74 m
4,95 m
3,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,39 m
5,29 m
4,76 m
4,74 m
Operating expense
10,18 m
8,03 m
9,71 m
7,94 m
Total operating expenses
10,18 m
8,03 m
9,71 m
7,94 m
Operating income
-10,18 m
-8,03 m
-9,71 m
-7,94 m
Other non operating income
-
951,74 k
-1,53 m
1,35 m
EBT including unusual items
-9,96 m
-7,21 m
-10,82 m
-6,08 m
EBT excluding unusual items
-9,96 m
-7,21 m
-10,82 m
-6,08 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,96 m
-7,21 m
-10,82 m
-6,08 m
Net profit margin
-
-
-
-
Earnings per share
-0,12
-0,07
-0,10
-0,05
Interest and investment income
122,26 k
175,21 k
200,72 k
201,33 k
Interest expense
-
-
-
-
Net interest expenses
122,26 k
175,21 k
200,72 k
201,33 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,17 m
-8,02 m
-9,70 m
-7,93 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme